High Granular Tick Data API: US Stocks Learn more

Aurinia Pharmaceuticals Inc icon

Aurinia Pharmaceuticals Inc (AUPH NASDAQ) stock market data APIs

$15.3124 -0.16(-1%)
as of November 17, 2026
Try our APIs with free plan!

Aurinia Pharmaceuticals Inc Financial Data Overview

Price chart is built with Anychart
ISIN: CA05156V**** The data is available with plans that include the Fundamentals API. Check our pricing page for details.

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. It also develops aritinercept, a dual inhibitor of B cell-activating factor and proliferation-inducing ligand for the potential treatment of autoimmune diseases. The company was founded in 1993 and is headquartered in Edmonton, Canada.

Prev. Close 15.3124
Open 15.15
High 15.438
Low 15.1127
52 wk Range 13.52-19.25
Market Cap 2 038 M
P/E Ratio 6.6711
Shares Outstanding 134 M
Revenue 322 M
EPS 0.23
Beta 1.342

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


ETFs with Aurinia Pharmaceuticals Inc (top by weight)

Ticker
100-day Price Change
Weight
SVAL.US iShares US Small Cap Value Factor ETF
-2.22 (-5.09%)
0.40
SMMV.US iShares MSCI USA Small-Cap Min Vol Factor ETF
-0.45 (-0.96%)
0.24
2B78.XETRA iShares Healthcare Innovation UCITS ETF USD (Acc)
1.02 (11.57%)
0.19
BTEC.SW iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) USD
0.19 (1.87%)
0.14
2B70.XETRA iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
0.66 (7.63%)
0.14

* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Aurinia Pharmaceuticals Inc data using free add-ons & libraries


Get Aurinia Pharmaceuticals Inc Fundamental Data

Aurinia Pharmaceuticals Inc logo

Aurinia Pharmaceuticals Inc Fundamental data includes:

  • Net Revenue: 322 M
  • EBITDA: 185 M
  • Earnings Per Share: 2
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Aurinia Pharmaceuticals Inc Earnings data

Corporate Events Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2026-10-30
  • EPS/Forecast: 0.2
GET THE PACKAGE

Get Aurinia Pharmaceuticals Inc End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE

Aurinia Pharmaceuticals Inc News

Get Aurinia Pharmaceuticals Inc fresh news feed via Financial News API

Corporate Events Calendar & News package for

$19.99/mo.

Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE

Send the request

Leave your email and our team will contact you ASAP.